Cart
sales@molnova.com
Gedatolisib
CAS No. 1197160-78-3
Gedatolisib ( PF-05212384;PKI-587 )
Catalog No. M10696 CAS No. 1197160-78-3
A highly potent, selective, dual PI3K/mTOR inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 214 | In Stock |
|
| 50MG | 402 | In Stock |
|
| 100MG | 597 | In Stock |
|
| 500MG | 1251 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGedatolisib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent, selective, dual PI3K/mTOR inhibitor.
-
DescriptionA highly potent, selective, dual PI3K/mTOR inhibitor with IC50 of 0.4/6/8/6/1.6 nM for PI3Kα/β/γ/δ/mTOR, respectively; also potently inhibits PI3Kα mutant H1047R and E545K with IC50 of 0.6 and 0.6 nM; prevents the pAkt at Thr 308 with IC50 of 8 nM, and suppresses pAkt S473 with IC50 of <10 nM in cells; demonstrates antitumor efficacy in both subcutaneous and orthotopic xenograft tumor models.Blood Cancer Phase 3 Clinical
-
SynonymsPF-05212384;PKI-587
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptormTOR;PI3Kα;PI3Kγ
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1197160-78-3
-
Formula Weight615.72
-
Molecular FormulaC32H41N9O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1=CC=C(C2=NC(N3CCOCC3)=NC(N4CCOCC4)=N2)C=C1)NC5=CC=C(C(N6CCC(N(C)C)CC6)=O)C=C5
-
Chemical Name1-(4-{[4-(Dimethylamino)-1-piperidinyl]carbonyl}phenyl)-3-{4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Venkatesan AM, et al. J Med Chem. 2010 Mar 25;53(6):2636-45.
2. Mallon R, et al. Clin Cancer Res. 2011 May 15;17(10):3193-203.
3. Gedaly R, et al. J Surg Res. 2013 Nov;185(1):225-30.
4. D'Amato V, et al. Br J Cancer. 2014 Jun 10;110(12):2887-95.
2. Mallon R, et al. Clin Cancer Res. 2011 May 15;17(10):3193-203.
3. Gedaly R, et al. J Surg Res. 2013 Nov;185(1):225-30.
4. D'Amato V, et al. Br J Cancer. 2014 Jun 10;110(12):2887-95.
molnova catalog
related products
-
MLN1117
MLN1117 (INK1117,TAK-117, Serabelisib) is a potent, selective PI3K p110α inhibitor with IC50 of 15 nM.
-
Idelalisib
Idelalisib is a selective inhibitor of p110δ(IC50 : 2.5 nM; in cell-free assays); shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.
-
A66
A66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor.
